| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -649.65K | -2.22M | -2.61M | -2.18M | -234.02K | -38.86K |
| EBITDA | -6.00M | -3.41K | -6.26M | -4.17M | -5.56M | -1.05M |
| Net Income | -6.76M | -8.20K | -16.49M | -11.44M | -6.33M | -804.37K |
Balance Sheet | ||||||
| Total Assets | 4.75M | 4.81M | 9.06M | 21.61M | 21.72M | 17.66M |
| Cash, Cash Equivalents and Short-Term Investments | 1.35M | 1.00M | 1.27M | 1.85M | 3.34M | 2.61M |
| Total Debt | 52.09K | 8.06K | 18.88K | 28.37K | 0.00 | 1.26M |
| Total Liabilities | 4.68M | 8.66M | 7.23M | 7.09M | 3.39M | 5.17M |
| Stockholders Equity | -795.48K | -4.65M | 1.25M | 14.39M | 18.33M | 12.49M |
Cash Flow | ||||||
| Free Cash Flow | -1.90M | -1.70M | -1.53M | -6.12M | -6.61M | -4.49M |
| Operating Cash Flow | -1.87M | -1.69M | -1.26M | -4.88M | -2.41M | -1.05M |
| Investing Cash Flow | 430.43K | 1.10M | -1.13M | -1.49M | -4.20M | -3.44M |
| Financing Cash Flow | 1.46M | 672.81K | 1.84M | 4.82M | 7.39M | 6.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | C$66.32M | 13.05 | 7.13% | ― | 1.04% | 107.55% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | C$140.87M | 24.17 | 15.11% | ― | -73.34% | 16.21% | |
53 Neutral | C$87.94M | -13.95 | -450.88% | ― | ― | -38.68% | |
51 Neutral | C$58.82M | -56.82 | -3.86% | ― | ― | ― | |
45 Neutral | C$27.19M | -30.30 | -2.06% | ― | ― | 93.75% | |
44 Neutral | C$78.56M | -11.05 | ― | ― | ― | 50.72% |
HPQ Silicon Inc. has increased its equity stake in French technology partner Novacium SAS by 8.4 percentage points, raising its ownership from 28.4% to 36.8% through the issuance of 22.4 million common shares at a deemed price of C$0.18 per share, implying an unchanged Novacium valuation of about €30 million. The move is designed to deepen HPQ’s participation in Novacium’s future global revenues and royalty streams, extend its share of value generated outside its licensed North American territory, and improve alignment on intellectual property and commercialization strategy, while management characterizes the deal as a disciplined, staged investment that increases economic exposure to technologies it believes have reduced technical risk and strong short- and medium-term potential, albeit at the cost of roughly 5.2% dilution for existing shareholders.
The most recent analyst rating on (TSE:HPQ) stock is a Hold with a C$0.18 price target. To see the full list of analyst forecasts on HPQ-Silicon Resources stock, see the TSE:HPQ Stock Forecast page.
HPQ Silicon Inc. announced that its fumed silica reactor pilot plant has successfully produced fumed silica independently verified by a potential customer as meeting or exceeding commercial grade 150 standards, including specific surface area and viscosity benchmarks. This confirmation shows that the pilot facility can replicate and in some respects improve upon lab-scale results verified by McGill University, with viscosity performance about 10% higher than typical grade 150, indicating strong rheology efficiency suited to high-performance industrial applications. The achievement marks a significant scaling milestone—about twentyfold from lab conditions—demonstrating that HPQ’s proprietary plasma-based, single-step process can deliver commercial-grade fumed silica directly from quartz using an all-electric, more sustainable, and chemical-free method, potentially enhancing the company’s competitive position in advanced materials markets and broadening its addressable industrial customer base.
The most recent analyst rating on (TSE:HPQ) stock is a Hold with a C$0.18 price target. To see the full list of analyst forecasts on HPQ-Silicon Resources stock, see the TSE:HPQ Stock Forecast page.
HPQ Silicon and its French partner Novacium have secured IEC 62133 certification for their cylindrical 18650 and 21700 ENDURA+ lithium-ion cells, adding to existing UN 38.3 and UL 1642 approvals and completing the core suite of globally recognized safety standards. This certification removes major regulatory barriers, significantly broadens market access across regions and end-use sectors, and enables the companies to shift from technical evaluations to full-scale commercial negotiations, customer qualification programs, and integration into international supply chains, supporting HPQ’s strategy to scale production, accelerate revenue generation, and strengthen its positioning in global energy storage markets.
The most recent analyst rating on (TSE:HPQ) stock is a Hold with a C$0.19 price target. To see the full list of analyst forecasts on HPQ-Silicon Resources stock, see the TSE:HPQ Stock Forecast page.
HPQ Silicon and its French technology partner Novacium have secured IEC 62133 certification for their cylindrical 18650 and 21700 ENDURA+ lithium-ion battery cells, confirming compliance with one of the most widely recognized international safety standards for portable rechargeable batteries. Combined with existing UN 38.3 and UL 1642 certifications, this completes a core suite of global safety approvals that removes key regulatory barriers, significantly broadens market access, and allows the partners to shift from technical testing to full-scale commercial negotiations, customer qualification programs, and integration into international supply chains, strengthening HPQ’s push to scale production and position itself as a provider of market-ready energy storage solutions.
The most recent analyst rating on (TSE:HPQ) stock is a Hold with a C$0.19 price target. To see the full list of analyst forecasts on HPQ-Silicon Resources stock, see the TSE:HPQ Stock Forecast page.
HPQ Silicon has secured UL 1642 certification for its HPQ ENDURA+ 18650 and 21700 lithium-ion cells, confirming compliance with the core safety standards required for commercial acceptance in the U.S. market. Together with its previously obtained UN 38.3 transport certification, this completes the key U.S. regulatory requirements for the ENDURA+ platform, removing a major barrier to entry and allowing HPQ to shift from validation to commercial execution, engage directly with North American OEMs, and pursue integration of its certified cells into existing supply chains and early commercial deployments.
The most recent analyst rating on (TSE:HPQ) stock is a Hold with a C$0.16 price target. To see the full list of analyst forecasts on HPQ-Silicon Resources stock, see the TSE:HPQ Stock Forecast page.
In its 2025 year-end update, HPQ Silicon reported a strategic shift from broad research and development toward a more execution-driven focus on commercializing its most advanced platforms in fumed silica and silicon-based battery materials. The company’s Fumed Silica Reactor, developed with PyroGenesis, progressed from pilot commissioning to industrial validation, demonstrating pilot-scale production, commercial-grade material properties, and lower-energy, lower-carbon one-step processing that positions HPQ to address growing global demand for fumed silica in batteries, energy systems, and data-centric infrastructure. At the same time, HPQ’s silicon-based anode materials initiative with Novacium SAS moved from lab validation into commercial-scale lithium-ion cell production, with GEN3 anode materials delivering over 1,000 charge cycles and at least 30% better performance than leading graphite-based cells, culminating in the launch of the HPQ ENDURA+ battery platform and marking a significant step toward near-term revenue and stronger competitive positioning in the battery materials market.
The most recent analyst rating on (TSE:HPQ) stock is a Hold with a C$0.16 price target. To see the full list of analyst forecasts on HPQ-Silicon Resources stock, see the TSE:HPQ Stock Forecast page.
HPQ Silicon Inc. has achieved UN 38.3 certification for its high-performance lithium-ion cells in the HPQ ENDURA+ line, specifically the 18650 and 21700 formats. This certification allows the company to proceed with global commercial shipments, marking a significant step in its transition from research to industrial supply. The certification ensures the cells meet international safety and transport standards, facilitating secure transport and accelerating commercial discussions. This milestone aligns with HPQ’s strategy to scale production and expand its market presence, with plans to achieve UL1642 certification for the U.S. market.
HPQ Silicon Inc. announced the closing of a non-brokered private placement, raising over $1 million to advance its core technology platforms. The funds will support commercialization initiatives for its Fumed Silica Reactor, HPQ ENDURA+ cells, and METAGENE hydrogen production platform. The participation of CEO Bernard Tourillon in the financing underscores confidence in HPQ’s strategy and long-term value creation. This investment will help the company transition its technologies from development to commercial readiness, maintaining momentum toward revenue-generating activities.
HPQ Silicon Inc. and its partner Novacium have signed an industrial cooperation agreement with AD-VENTA to enhance the production capacity of the METAGENE™ process for green hydrogen. This partnership aims to scale up the METAGENE™ technology, which can produce up to 20 kilograms of hydrogen per day, significantly boosting its capacity and accelerating its deployment. The integration of METAGENE™ into AD-VENTA’s existing hydrogen distribution infrastructure is expected to provide a more efficient and autonomous hydrogen production solution, particularly beneficial for off-grid applications and regions with logistical challenges.
HPQ Silicon Inc. announced the successful closure of a non-brokered private placement, raising $306,120 through the issuance of 1,883,815 common shares. This financing, completed with a European investment firm, will support HPQ’s general working capital and advance its battery-related initiatives and R&D projects. The placement underscores HPQ’s value proposition by securing funds without incurring finder’s fees, enhancing its flexibility to pursue larger opportunities. The move is expected to bolster HPQ’s position in the advanced materials and energy sectors, aligning with its strategic goals.
HPQ Silicon Inc. announced a significant milestone with the successful production of commercial-grade fumed silica at pilot scale, validated by independent laboratory analysis. The results demonstrate improved purity and surface area, confirming the scalability and performance of their proprietary reactor technology. This advancement positions HPQ to meet high commercial specifications while offering substantial environmental and cost advantages over traditional manufacturing methods. The company’s process eliminates toxic chemical inputs and significantly reduces energy consumption and emissions, aligning with modern sustainability goals and offering potential cost savings.
HPQ Silicon Inc. welcomes Canada’s 2025 Federal Budget, which allocates $141 billion towards enhancing industrial capacity, clean-energy infrastructure, and commercialization of next-generation technologies. The budget’s emphasis on productivity and clean manufacturing aligns with HPQ’s core technologies, supporting their domestic production and reducing reliance on imports. The budget’s incentives are expected to facilitate HPQ’s scale-up of Fumed Silica production, HPQ ENDURA+ Batteries, and METAGENE™ Hydrogen, positioning the company advantageously within Canada’s clean-tech manufacturing landscape.